706 filings
Page 14 of 36
8-K
TLPH
Talphera Inc.
4 Jun 20
AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
4:05pm
8-K
TLPH
Talphera Inc.
29 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:12pm
425
TLPH
Talphera Inc.
29 May 20
Business combination disclosure
5:10pm
425
TLPH
Talphera Inc.
29 May 20
Business combination disclosure
8:54am
8-K
TLPH
Talphera Inc.
27 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:03pm
425
TLPH
Talphera Inc.
27 May 20
Business combination disclosure
5:01pm
425
TLPH
Talphera Inc.
27 May 20
Business combination disclosure
9:29am
8-K
TLPH
Talphera Inc.
22 May 20
Termination of a Material Definitive Agreement
4:11pm
425
TLPH
Talphera Inc.
12 May 20
Business combination disclosure
4:10pm
10-Q
2020 Q1
TLPH
Talphera Inc.
Quarterly report
11 May 20
4:37pm
425
TLPH
Talphera Inc.
11 May 20
Business combination disclosure
4:06pm
8-K
TLPH
Talphera Inc.
11 May 20
AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results
4:05pm
8-K
TLPH
Talphera Inc.
30 Apr 20
AcelRx Announces DSUVIA® Milestone C Approval
8:24am
425
TTPH
Tetraphase Pharmaceuticals Inc
30 Apr 20
Business combination disclosure
8:22am
EFFECT
TLPH
Talphera Inc.
27 Apr 20
Notice of effectiveness
12:15am
424B3
TLPH
Talphera Inc.
24 Apr 20
Prospectus supplement
4:05pm
DEFA14A
TLPH
Talphera Inc.
24 Apr 20
Additional proxy soliciting materials
6:09am
DEF 14A
TLPH
Talphera Inc.
Definitive proxy
24 Apr 20
6:07am
CORRESP
TLPH
Talphera Inc.
22 Apr 20
Correspondence with SEC
12:00am
S-4/A
TLPH
Talphera Inc.
21 Apr 20
Registration of securities issued in business combination transactions (amended)
5:09pm